The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health conditions, the company said on Friday, sending its shares surging 30% in ...

Researchers at the University of Seville have analyzed alterations in the cerebral cortex in people suffering from psychosis. Their findings show that psychosis does not follow a single trajectory, ...

Researchers at the University of Seville have analyzed alterations in the cerebral cortex in people suffering from psychosis.

Vanda Pharmaceuticals had 9% revenue growth and heavy losses with a 1.4x sales valuation and a PDUFA date. Check out why VNDA stock is downgraded to hold.

Newron secures up to EUR 38 million to advance its ENIGMA-TRS pivotal phase III programme: Milan, Italy Wednesday, February 18, 2026, 18:00 Hrs [IST] Newron Pharmaceuticals SpA, a ...

The U.S. Food and Drug Administration approved Cobenfy on September 26, 2024, making it the first schizophrenia drug with a ...

Proceeds expected to fund global ENIGMA-TRS studies and extend cash runway beyond pivotal 12-week results, supporting development of evenamide as the potential first add-on therapy for ...

However, the opioid pathway, a heavily studied physiologic pathway inextricably intertwined with behaviour and reward, rarely receives attention within psychiatric practice. Although the opioid system ...

Drug treatments for schizophrenia have barely changed in 70 years, but a mix of chance and ingenuity offers fresh hope ...

Tesla is known for innovative brand-exclusive features made possible by its advanced software. From Dog Mode to Sentry Mode, the electric vehicles have more than one interesting setting that enables ...